#Latest news with #liverFailureReuters13 hours agoHealthReutersFDA investigates patient deaths after treatment with Sarepta's gene therapyJune 24 (Reuters) - The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver failure in non-ambulatory Duchenne muscular dystrophy patients after receiving Sarepta Therapeutics' (SRPT.O), opens new tab gene therapy, Elevidys.
Reuters13 hours agoHealthReutersFDA investigates patient deaths after treatment with Sarepta's gene therapyJune 24 (Reuters) - The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver failure in non-ambulatory Duchenne muscular dystrophy patients after receiving Sarepta Therapeutics' (SRPT.O), opens new tab gene therapy, Elevidys.
13 hours ago
